Pharma-Bio Serv, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was $19K, a 69% decline year-over-year.
  • Pharma-Bio Serv, Inc. Income Tax Expense (Benefit) for the twelve months ending July 31, 2024 was $52.4K, a 88% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2023 was $377K, a 108% increase from 2022.
  • Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2022 was $182K, a 14.8% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Income Tax Expense (Benefit) for 2021 was $213K, a 10.8% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $52.4K $19K -$42.2K -69% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $94.6K $21.2K -$147K -87.4% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $242K $12.9K -$136K -91.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $377K -$687 -$58.4K -101% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $436K $61.2K +$33.4K +120% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $402K $168K +$123K +273% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $279K $149K +$97.5K +190% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $182K $57.7K -$18.2K -24% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 $200K $27.8K -$10.5K -27.4% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 $210K $45K -$591 -1.3% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $211K $51.2K -$2.27K -4.25% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $213K $75.9K +$67.9K +848% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $145K $38.3K -$56.1K -59.5% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $201K $45.6K -$35.8K -44% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $237K $53.5K -$1.8K -3.26% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $239K $8.01K +$1.61K +25.1% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $237K $94.4K +$83K +729% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $154K $81.4K +$6.15K +8.17% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $148K $55.3K +$12.3K +28.7% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $136K $6.4K -$25.1K -79.7% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $161K $11.4K -$41.6K -78.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $203K $75.3K +$75.3K Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $127K $43K -$2.66M -98.4% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $2.79M $31.5K +$30.9K +4678% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 $2.75M $53K +$51.6K +3823% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $2.7M $0 -$106 Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $2.7M $2.7M +$2.7M +154244% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 $3.87K $660 -$521 -44.1% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 $4.39K $1.35K -$11.3K -89.3% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $15.7K $106* -$7.46K Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 $23.2K $1.75K -$29.7K -94.4% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 $52.8K $1.18K -$54.6K -97.9% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 $107K $12.7K -$28.5K -69.2% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $136K $7.57K -$24.7K -76.5% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $161K $31.4K -$7.4K -19.1% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $168K $55.8K -$52K -48.3% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 $220K $41.1K -$59.3K -59% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $279K $32.2K -$58.4K -64.4% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 $338K $38.8K -$127K -76.6% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $465K $108K -$176K -62% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 $641K $100K -$187K -65.1% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 $828K $90.6K -$271K -74.9% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 $1.1M $166K -$71.6K -30.2% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $1.17M $284K -$32.6K -10.3% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 $1.2M $288K -$9.65K -3.25% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $1.21M $361K +$123K +51.8% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 $1.09M $237K +$20.2K +9.28% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $1.07M $316K +$107K +51.4% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 $961K $297K +$625K May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $336K $238K -$21.5K -8.29% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $357K $217K +$52.5K +31.9% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $305K $209K Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 -$328K -$413K -487% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 $259K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $165K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 $84.8K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.